instruction stringlengths 34 186 | input stringlengths 2.02k 93.8k | output stringlengths 2 418 | meta_questiontype stringclasses 6
values | meta_inputlicense stringclasses 6
values | meta_pmid stringlengths 8 8 | meta_safetyreportid int64 9.51M 21M | meta_articlepubdate stringlengths 4 10 |
|---|---|---|---|---|---|---|---|
What was the administration route of drug 'METHOTREXATE'? | Outcomes of Burkitt lymphoma with bone marrow involvement or Burkitt leukemia in Chinese children.
Burkitt lymphoma with bone marrow involvement and Burkitt leukemia behave aggressively. Thus far, there are limited data concerning survival and toxicity in Chinese children with Burkitt lymphoma or Burkitt leukemia who h... | Intrathecal | DrugAdministrationRoute | CC BY-NC-ND | 34179707 | 19,846,059 | 2021-06 |
What was the administration route of drug 'RITUXIMAB'? | Outcomes of Burkitt lymphoma with bone marrow involvement or Burkitt leukemia in Chinese children.
Burkitt lymphoma with bone marrow involvement and Burkitt leukemia behave aggressively. Thus far, there are limited data concerning survival and toxicity in Chinese children with Burkitt lymphoma or Burkitt leukemia who h... | Intravenous drip | DrugAdministrationRoute | CC BY-NC-ND | 34179707 | 19,846,059 | 2021-06 |
What was the dosage of drug 'RITUXIMAB'? | Outcomes of Burkitt lymphoma with bone marrow involvement or Burkitt leukemia in Chinese children.
Burkitt lymphoma with bone marrow involvement and Burkitt leukemia behave aggressively. Thus far, there are limited data concerning survival and toxicity in Chinese children with Burkitt lymphoma or Burkitt leukemia who h... | ON DAY 0 | DrugDosageText | CC BY-NC-ND | 34179707 | 19,846,059 | 2021-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug ineffective'. | Fenfluramine in the successful treatment of super-refractory status epilepticus in a patient with Dravet syndrome.
A 20-year-old woman with Dravet syndrome and multiple prior episodes of status epilepticus presented to our hospital in November 2018 in super-refractory status epilepticus. After 5 weeks of unsuccessful c... | CLOBAZAM, LEVETIRACETAM, LEVOCARNITINE, LORAZEPAM, MIDAZOLAM, PROPOFOL, VALPROIC ACID | DrugsGivenReaction | CC BY-NC-ND | 34179745 | 20,247,004 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Generalised tonic-clonic seizure'. | Fenfluramine in the successful treatment of super-refractory status epilepticus in a patient with Dravet syndrome.
A 20-year-old woman with Dravet syndrome and multiple prior episodes of status epilepticus presented to our hospital in November 2018 in super-refractory status epilepticus. After 5 weeks of unsuccessful c... | BRIVARACETAM, CANNABIDIOL, CLOBAZAM, FELBAMATE, FENFLURAMINE, KETAMINE, LEVETIRACETAM, LEVOCARNITINE, LORAZEPAM, MIDAZOLAM, PHENOBARBITAL, PROPOFOL, VALPROIC ACID | DrugsGivenReaction | CC BY-NC-ND | 34179745 | 20,233,182 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Multiple-drug resistance'. | Fenfluramine in the successful treatment of super-refractory status epilepticus in a patient with Dravet syndrome.
A 20-year-old woman with Dravet syndrome and multiple prior episodes of status epilepticus presented to our hospital in November 2018 in super-refractory status epilepticus. After 5 weeks of unsuccessful c... | BRIVARACETAM, CANNABIDIOL, CLOBAZAM, FELBAMATE, FENFLURAMINE, KETAMINE, LEVETIRACETAM, LEVOCARNITINE, LORAZEPAM, MIDAZOLAM, PHENOBARBITAL, PROPOFOL, VALPROIC ACID | DrugsGivenReaction | CC BY-NC-ND | 34179745 | 20,233,182 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Parainfluenzae virus infection'. | Fenfluramine in the successful treatment of super-refractory status epilepticus in a patient with Dravet syndrome.
A 20-year-old woman with Dravet syndrome and multiple prior episodes of status epilepticus presented to our hospital in November 2018 in super-refractory status epilepticus. After 5 weeks of unsuccessful c... | BRIVARACETAM, CANNABIDIOL, CLOBAZAM, FELBAMATE, FENFLURAMINE, KETAMINE, LEVETIRACETAM, LEVOCARNITINE, LORAZEPAM, MIDAZOLAM, PHENOBARBITAL, PROPOFOL, VALPROIC ACID | DrugsGivenReaction | CC BY-NC-ND | 34179745 | 20,233,182 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Product use in unapproved indication'. | Fenfluramine in the successful treatment of super-refractory status epilepticus in a patient with Dravet syndrome.
A 20-year-old woman with Dravet syndrome and multiple prior episodes of status epilepticus presented to our hospital in November 2018 in super-refractory status epilepticus. After 5 weeks of unsuccessful c... | BRIVARACETAM, CANNABIDIOL, CLOBAZAM, FELBAMATE, FENFLURAMINE, KETAMINE, LEVETIRACETAM, LEVOCARNITINE, LORAZEPAM, MIDAZOLAM, PHENOBARBITAL, PROPOFOL, VALPROIC ACID | DrugsGivenReaction | CC BY-NC-ND | 34179745 | 20,233,182 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Propofol infusion syndrome'. | Fenfluramine in the successful treatment of super-refractory status epilepticus in a patient with Dravet syndrome.
A 20-year-old woman with Dravet syndrome and multiple prior episodes of status epilepticus presented to our hospital in November 2018 in super-refractory status epilepticus. After 5 weeks of unsuccessful c... | CLOBAZAM, LEVETIRACETAM, LEVOCARNITINE, LORAZEPAM, MIDAZOLAM, PROPOFOL, VALPROIC ACID | DrugsGivenReaction | CC BY-NC-ND | 34179745 | 20,220,202 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Seizure'. | Fenfluramine in the successful treatment of super-refractory status epilepticus in a patient with Dravet syndrome.
A 20-year-old woman with Dravet syndrome and multiple prior episodes of status epilepticus presented to our hospital in November 2018 in super-refractory status epilepticus. After 5 weeks of unsuccessful c... | LAMOTRIGINE | DrugsGivenReaction | CC BY-NC-ND | 34179745 | 20,226,443 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Tonic convulsion'. | Fenfluramine in the successful treatment of super-refractory status epilepticus in a patient with Dravet syndrome.
A 20-year-old woman with Dravet syndrome and multiple prior episodes of status epilepticus presented to our hospital in November 2018 in super-refractory status epilepticus. After 5 weeks of unsuccessful c... | BRIVARACETAM, CANNABIDIOL, CLOBAZAM, FELBAMATE, FENFLURAMINE, KETAMINE, LEVETIRACETAM, LEVOCARNITINE, LORAZEPAM, MIDAZOLAM, PHENOBARBITAL, PROPOFOL, VALPROIC ACID | DrugsGivenReaction | CC BY-NC-ND | 34179745 | 20,233,182 | 2021 |
What was the administration route of drug 'LORAZEPAM'? | Fenfluramine in the successful treatment of super-refractory status epilepticus in a patient with Dravet syndrome.
A 20-year-old woman with Dravet syndrome and multiple prior episodes of status epilepticus presented to our hospital in November 2018 in super-refractory status epilepticus. After 5 weeks of unsuccessful c... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC-ND | 34179745 | 20,247,004 | 2021 |
What was the administration route of drug 'MIDAZOLAM'? | Fenfluramine in the successful treatment of super-refractory status epilepticus in a patient with Dravet syndrome.
A 20-year-old woman with Dravet syndrome and multiple prior episodes of status epilepticus presented to our hospital in November 2018 in super-refractory status epilepticus. After 5 weeks of unsuccessful c... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC-ND | 34179745 | 20,247,004 | 2021 |
What was the administration route of drug 'PROPOFOL'? | Fenfluramine in the successful treatment of super-refractory status epilepticus in a patient with Dravet syndrome.
A 20-year-old woman with Dravet syndrome and multiple prior episodes of status epilepticus presented to our hospital in November 2018 in super-refractory status epilepticus. After 5 weeks of unsuccessful c... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC-ND | 34179745 | 20,247,004 | 2021 |
What was the dosage of drug 'BRIVARACETAM'? | Fenfluramine in the successful treatment of super-refractory status epilepticus in a patient with Dravet syndrome.
A 20-year-old woman with Dravet syndrome and multiple prior episodes of status epilepticus presented to our hospital in November 2018 in super-refractory status epilepticus. After 5 weeks of unsuccessful c... | 100 MILLIGRAM, 2X/DAY (BID) | DrugDosageText | CC BY-NC-ND | 34179745 | 20,233,182 | 2021 |
What was the dosage of drug 'CANNABIDIOL'? | Fenfluramine in the successful treatment of super-refractory status epilepticus in a patient with Dravet syndrome.
A 20-year-old woman with Dravet syndrome and multiple prior episodes of status epilepticus presented to our hospital in November 2018 in super-refractory status epilepticus. After 5 weeks of unsuccessful c... | 10 MILLIGRAM/KILOGRAM DAY | DrugDosageText | CC BY-NC-ND | 34179745 | 20,233,182 | 2021 |
What was the dosage of drug 'FELBAMATE'? | Fenfluramine in the successful treatment of super-refractory status epilepticus in a patient with Dravet syndrome.
A 20-year-old woman with Dravet syndrome and multiple prior episodes of status epilepticus presented to our hospital in November 2018 in super-refractory status epilepticus. After 5 weeks of unsuccessful c... | 600 MILLIGRAM, 3X/DAY (TID) | DrugDosageText | CC BY-NC-ND | 34179745 | 20,233,182 | 2021 |
What was the dosage of drug 'PHENOBARBITAL'? | Fenfluramine in the successful treatment of super-refractory status epilepticus in a patient with Dravet syndrome.
A 20-year-old woman with Dravet syndrome and multiple prior episodes of status epilepticus presented to our hospital in November 2018 in super-refractory status epilepticus. After 5 weeks of unsuccessful c... | 97.2 MILLIGRAM, 2X/DAY (BID) | DrugDosageText | CC BY-NC-ND | 34179745 | 20,233,182 | 2021 |
What was the dosage of drug 'PROPOFOL'? | Fenfluramine in the successful treatment of super-refractory status epilepticus in a patient with Dravet syndrome.
A 20-year-old woman with Dravet syndrome and multiple prior episodes of status epilepticus presented to our hospital in November 2018 in super-refractory status epilepticus. After 5 weeks of unsuccessful c... | 100 UNK, 100 MCG/ KG/ MINUTE | DrugDosageText | CC BY-NC-ND | 34179745 | 20,247,004 | 2021 |
What was the outcome of reaction 'Generalised tonic-clonic seizure'? | Fenfluramine in the successful treatment of super-refractory status epilepticus in a patient with Dravet syndrome.
A 20-year-old woman with Dravet syndrome and multiple prior episodes of status epilepticus presented to our hospital in November 2018 in super-refractory status epilepticus. After 5 weeks of unsuccessful c... | Recovering | ReactionOutcome | CC BY-NC-ND | 34179745 | 20,233,182 | 2021 |
What was the outcome of reaction 'Tonic convulsion'? | Fenfluramine in the successful treatment of super-refractory status epilepticus in a patient with Dravet syndrome.
A 20-year-old woman with Dravet syndrome and multiple prior episodes of status epilepticus presented to our hospital in November 2018 in super-refractory status epilepticus. After 5 weeks of unsuccessful c... | Recovering | ReactionOutcome | CC BY-NC-ND | 34179745 | 20,233,182 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Cytomegalovirus infection'. | Macrophage Activation Syndrome in Adults: A Retrospective Case Series.
Macrophage activation syndrome (MAS) is a form of hemophagocytic lymphohistocytosis that occurs in patients with a variety of inflammatory rheumatologic conditions. Traditionally, it is noted in pediatric patients with systemic juvenile idiopathic a... | METHOTREXATE, MYCOPHENOLATE MOFETIL, RITUXIMAB | DrugsGivenReaction | CC BY-NC | 34180255 | 20,314,820 | 2021 |
What was the outcome of reaction 'Pancreatitis acute'? | Pravastatin-Induced Acute Pancreatitis: A Case Report and Literature Review.
Pancreatitis is inflammation of pancreas associated most commonly with chronic alcoholism and gallstones. Other less common causes of pancreatitis are hyperlipidemia, infections, surgery, trauma, post endoscopic retrograde cholangiopancreatogr... | Recovered | ReactionOutcome | CC BY-NC | 34180257 | 19,624,517 | 2021 |
What was the outcome of reaction 'Small intestinal obstruction'? | Pravastatin-Induced Acute Pancreatitis: A Case Report and Literature Review.
Pancreatitis is inflammation of pancreas associated most commonly with chronic alcoholism and gallstones. Other less common causes of pancreatitis are hyperlipidemia, infections, surgery, trauma, post endoscopic retrograde cholangiopancreatogr... | Recovered | ReactionOutcome | CC BY-NC | 34180257 | 19,609,376 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Diarrhoea'. | Concurrent chemotherapy and first-generation epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitors (TKIs) with or without an antiangiogenic agent as first-line treatment in advanced lung adenocarcinoma harboring an EGFR mutation.
Previous studies have demonstrated the combination of epidermal growth factor... | BEVACIZUMAB, ERLOTINIB, GEFITINIB, ICOTINIB, PEMETREXED | DrugsGivenReaction | CC BY-NC-ND | 34180588 | 19,570,372 | 2021-08 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug resistance'. | Concurrent chemotherapy and first-generation epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitors (TKIs) with or without an antiangiogenic agent as first-line treatment in advanced lung adenocarcinoma harboring an EGFR mutation.
Previous studies have demonstrated the combination of epidermal growth factor... | BEVACIZUMAB, ERLOTINIB, GEFITINIB, ICOTINIB, PEMETREXED | DrugsGivenReaction | CC BY-NC-ND | 34180588 | 19,570,372 | 2021-08 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Fatigue'. | Concurrent chemotherapy and first-generation epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitors (TKIs) with or without an antiangiogenic agent as first-line treatment in advanced lung adenocarcinoma harboring an EGFR mutation.
Previous studies have demonstrated the combination of epidermal growth factor... | BEVACIZUMAB, ERLOTINIB, GEFITINIB, ICOTINIB, PEMETREXED | DrugsGivenReaction | CC BY-NC-ND | 34180588 | 19,570,372 | 2021-08 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Hepatotoxicity'. | Concurrent chemotherapy and first-generation epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitors (TKIs) with or without an antiangiogenic agent as first-line treatment in advanced lung adenocarcinoma harboring an EGFR mutation.
Previous studies have demonstrated the combination of epidermal growth factor... | BEVACIZUMAB, ERLOTINIB, GEFITINIB, ICOTINIB, PEMETREXED | DrugsGivenReaction | CC BY-NC-ND | 34180588 | 19,570,372 | 2021-08 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Hypertension'. | Concurrent chemotherapy and first-generation epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitors (TKIs) with or without an antiangiogenic agent as first-line treatment in advanced lung adenocarcinoma harboring an EGFR mutation.
Previous studies have demonstrated the combination of epidermal growth factor... | BEVACIZUMAB, ERLOTINIB, GEFITINIB, ICOTINIB, PEMETREXED | DrugsGivenReaction | CC BY-NC-ND | 34180588 | 19,570,372 | 2021-08 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Leukopenia'. | Concurrent chemotherapy and first-generation epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitors (TKIs) with or without an antiangiogenic agent as first-line treatment in advanced lung adenocarcinoma harboring an EGFR mutation.
Previous studies have demonstrated the combination of epidermal growth factor... | BEVACIZUMAB, ERLOTINIB, GEFITINIB, ICOTINIB, PEMETREXED | DrugsGivenReaction | CC BY-NC-ND | 34180588 | 19,570,372 | 2021-08 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Neutropenia'. | Concurrent chemotherapy and first-generation epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitors (TKIs) with or without an antiangiogenic agent as first-line treatment in advanced lung adenocarcinoma harboring an EGFR mutation.
Previous studies have demonstrated the combination of epidermal growth factor... | BEVACIZUMAB, ERLOTINIB, GEFITINIB, ICOTINIB, PEMETREXED | DrugsGivenReaction | CC BY-NC-ND | 34180588 | 19,570,372 | 2021-08 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Rash'. | Concurrent chemotherapy and first-generation epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitors (TKIs) with or without an antiangiogenic agent as first-line treatment in advanced lung adenocarcinoma harboring an EGFR mutation.
Previous studies have demonstrated the combination of epidermal growth factor... | BEVACIZUMAB, ERLOTINIB, GEFITINIB, ICOTINIB, PEMETREXED | DrugsGivenReaction | CC BY-NC-ND | 34180588 | 19,570,372 | 2021-08 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Venous thrombosis'. | Concurrent chemotherapy and first-generation epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitors (TKIs) with or without an antiangiogenic agent as first-line treatment in advanced lung adenocarcinoma harboring an EGFR mutation.
Previous studies have demonstrated the combination of epidermal growth factor... | BEVACIZUMAB, ERLOTINIB, GEFITINIB, ICOTINIB, PEMETREXED | DrugsGivenReaction | CC BY-NC-ND | 34180588 | 19,570,372 | 2021-08 |
What was the administration route of drug 'ERLOTINIB'? | Concurrent chemotherapy and first-generation epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitors (TKIs) with or without an antiangiogenic agent as first-line treatment in advanced lung adenocarcinoma harboring an EGFR mutation.
Previous studies have demonstrated the combination of epidermal growth factor... | Oral | DrugAdministrationRoute | CC BY-NC-ND | 34180588 | 19,570,372 | 2021-08 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Cardiogenic shock'. | Plasma procalcitonin may be an early predictor of liver injury in acetaminophen poisoning: A prospective cohort study.
Acetaminophen is a common cause of poisoning and liver injury worldwide; however, patient stratification is suboptimal. We aimed to assess the contribution of admission plasma procalcitonin concentrati... | ACETAMINOPHEN | DrugsGivenReaction | CC BY-NC-ND | 34181312 | 19,968,399 | 2021-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug-induced liver injury'. | Plasma procalcitonin may be an early predictor of liver injury in acetaminophen poisoning: A prospective cohort study.
Acetaminophen is a common cause of poisoning and liver injury worldwide; however, patient stratification is suboptimal. We aimed to assess the contribution of admission plasma procalcitonin concentrati... | ACETAMINOPHEN | DrugsGivenReaction | CC BY-NC-ND | 34181312 | 20,005,241 | 2021-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Overdose'. | Plasma procalcitonin may be an early predictor of liver injury in acetaminophen poisoning: A prospective cohort study.
Acetaminophen is a common cause of poisoning and liver injury worldwide; however, patient stratification is suboptimal. We aimed to assess the contribution of admission plasma procalcitonin concentrati... | ACETAMINOPHEN | DrugsGivenReaction | CC BY-NC-ND | 34181312 | 19,970,198 | 2021-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Procalcitonin increased'. | Plasma procalcitonin may be an early predictor of liver injury in acetaminophen poisoning: A prospective cohort study.
Acetaminophen is a common cause of poisoning and liver injury worldwide; however, patient stratification is suboptimal. We aimed to assess the contribution of admission plasma procalcitonin concentrati... | ACETAMINOPHEN\HYDROCODONE | DrugsGivenReaction | CC BY-NC-ND | 34181312 | 19,607,287 | 2021-06 |
What was the administration route of drug 'ACETAMINOPHEN'? | Plasma procalcitonin may be an early predictor of liver injury in acetaminophen poisoning: A prospective cohort study.
Acetaminophen is a common cause of poisoning and liver injury worldwide; however, patient stratification is suboptimal. We aimed to assess the contribution of admission plasma procalcitonin concentrati... | Oral | DrugAdministrationRoute | CC BY-NC-ND | 34181312 | 19,968,399 | 2021-06 |
What was the administration route of drug 'ACETAMINOPHEN\HYDROCODONE'? | Plasma procalcitonin may be an early predictor of liver injury in acetaminophen poisoning: A prospective cohort study.
Acetaminophen is a common cause of poisoning and liver injury worldwide; however, patient stratification is suboptimal. We aimed to assess the contribution of admission plasma procalcitonin concentrati... | Oral | DrugAdministrationRoute | CC BY-NC-ND | 34181312 | 19,607,287 | 2021-06 |
What was the dosage of drug 'ACETAMINOPHEN\HYDROCODONE'? | Plasma procalcitonin may be an early predictor of liver injury in acetaminophen poisoning: A prospective cohort study.
Acetaminophen is a common cause of poisoning and liver injury worldwide; however, patient stratification is suboptimal. We aimed to assess the contribution of admission plasma procalcitonin concentrati... | UNKNOWN | DrugDosageText | CC BY-NC-ND | 34181312 | 19,607,287 | 2021-06 |
What was the outcome of reaction 'Cardiogenic shock'? | Plasma procalcitonin may be an early predictor of liver injury in acetaminophen poisoning: A prospective cohort study.
Acetaminophen is a common cause of poisoning and liver injury worldwide; however, patient stratification is suboptimal. We aimed to assess the contribution of admission plasma procalcitonin concentrati... | Fatal | ReactionOutcome | CC BY-NC-ND | 34181312 | 19,968,399 | 2021-06 |
What was the outcome of reaction 'Overdose'? | Plasma procalcitonin may be an early predictor of liver injury in acetaminophen poisoning: A prospective cohort study.
Acetaminophen is a common cause of poisoning and liver injury worldwide; however, patient stratification is suboptimal. We aimed to assess the contribution of admission plasma procalcitonin concentrati... | Fatal | ReactionOutcome | CC BY-NC-ND | 34181312 | 19,968,399 | 2021-06 |
What was the outcome of reaction 'Toxicity to various agents'? | Plasma procalcitonin may be an early predictor of liver injury in acetaminophen poisoning: A prospective cohort study.
Acetaminophen is a common cause of poisoning and liver injury worldwide; however, patient stratification is suboptimal. We aimed to assess the contribution of admission plasma procalcitonin concentrati... | Fatal | ReactionOutcome | CC BY-NC-ND | 34181312 | 19,968,399 | 2021-06 |
What was the administration route of drug 'GANCICLOVIR'? | Use of letermovir-valganciclovir combination as a step-down treatment after foscarnet for ganciclovir-resistant CMV infection in kidney transplant recipients.
BACKGROUND
Letermovir (LTV) might be an alternative treatment to nephrotoxic foscarnet (FOS) in Ganciclovir (GCV) resistant cytomegalovirus (CMV) infection. Howe... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC | 34181768 | 19,559,857 | 2021-11 |
What was the dosage of drug 'GANCICLOVIR'? | Use of letermovir-valganciclovir combination as a step-down treatment after foscarnet for ganciclovir-resistant CMV infection in kidney transplant recipients.
BACKGROUND
Letermovir (LTV) might be an alternative treatment to nephrotoxic foscarnet (FOS) in Ganciclovir (GCV) resistant cytomegalovirus (CMV) infection. Howe... | 5 MG/KG, BID | DrugDosageText | CC BY-NC | 34181768 | 19,559,857 | 2021-11 |
What was the dosage of drug 'VALGANCICLOVIR'? | Use of letermovir-valganciclovir combination as a step-down treatment after foscarnet for ganciclovir-resistant CMV infection in kidney transplant recipients.
BACKGROUND
Letermovir (LTV) might be an alternative treatment to nephrotoxic foscarnet (FOS) in Ganciclovir (GCV) resistant cytomegalovirus (CMV) infection. Howe... | 3? 6 MONTHS | DrugDosageText | CC BY-NC | 34181768 | 19,559,857 | 2021-11 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Genital haemorrhage'. | Long-term complications after stent assist coiling dependent on clopidogrel response.
BACKGROUND
Dual antiplatelet therapy (DAPT) is necessary for stent assisted coiling. However, long term use of DAPT has a potential risk of hemorrhagic events. We aimed to examine the relationship between clopidogrel reactivity and co... | ASPIRIN, CLOPIDOGREL BISULFATE, HEPARIN SODIUM | DrugsGivenReaction | CC BY | 34182941 | 19,554,509 | 2021-06-28 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Haemoglobin decreased'. | Long-term complications after stent assist coiling dependent on clopidogrel response.
BACKGROUND
Dual antiplatelet therapy (DAPT) is necessary for stent assisted coiling. However, long term use of DAPT has a potential risk of hemorrhagic events. We aimed to examine the relationship between clopidogrel reactivity and co... | ASPIRIN, CLOPIDOGREL BISULFATE, HEPARIN SODIUM | DrugsGivenReaction | CC BY | 34182941 | 19,554,509 | 2021-06-28 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Haemorrhagic infarction'. | Long-term complications after stent assist coiling dependent on clopidogrel response.
BACKGROUND
Dual antiplatelet therapy (DAPT) is necessary for stent assisted coiling. However, long term use of DAPT has a potential risk of hemorrhagic events. We aimed to examine the relationship between clopidogrel reactivity and co... | ASPIRIN, CLOPIDOGREL BISULFATE, HEPARIN SODIUM | DrugsGivenReaction | CC BY | 34182941 | 19,554,489 | 2021-06-28 |
What was the administration route of drug 'HEPARIN SODIUM'? | Long-term complications after stent assist coiling dependent on clopidogrel response.
BACKGROUND
Dual antiplatelet therapy (DAPT) is necessary for stent assisted coiling. However, long term use of DAPT has a potential risk of hemorrhagic events. We aimed to examine the relationship between clopidogrel reactivity and co... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 34182941 | 19,554,509 | 2021-06-28 |
What was the dosage of drug 'ASPIRIN'? | Long-term complications after stent assist coiling dependent on clopidogrel response.
BACKGROUND
Dual antiplatelet therapy (DAPT) is necessary for stent assisted coiling. However, long term use of DAPT has a potential risk of hemorrhagic events. We aimed to examine the relationship between clopidogrel reactivity and co... | 100 mg (milligrams). | DrugDosage | CC BY | 34182941 | 19,554,509 | 2021-06-28 |
What was the dosage of drug 'CLOPIDOGREL BISULFATE'? | Long-term complications after stent assist coiling dependent on clopidogrel response.
BACKGROUND
Dual antiplatelet therapy (DAPT) is necessary for stent assisted coiling. However, long term use of DAPT has a potential risk of hemorrhagic events. We aimed to examine the relationship between clopidogrel reactivity and co... | 75 mg (milligrams). | DrugDosage | CC BY | 34182941 | 19,554,509 | 2021-06-28 |
What was the dosage of drug 'HEPARIN SODIUM'? | Long-term complications after stent assist coiling dependent on clopidogrel response.
BACKGROUND
Dual antiplatelet therapy (DAPT) is necessary for stent assisted coiling. However, long term use of DAPT has a potential risk of hemorrhagic events. We aimed to examine the relationship between clopidogrel reactivity and co... | 10,000 UNITS FOR 2 DAYS | DrugDosageText | CC BY | 34182941 | 19,554,509 | 2021-06-28 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Disease progression'. | Changes in carnitine levels through induction chemotherapy in head and neck cancer patients as a potential cause of therapy-related malaise.
BACKGROUND
Carnitine is related to malaise, and cisplatin is associated with decreased carnitine. The purpose of this study was to elucidate the effects of one course of induction... | CISPLATIN, DOCETAXEL, FLUOROURACIL | DrugsGivenReaction | CC BY | 34182942 | 20,551,625 | 2021-06-28 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Therapy partial responder'. | Changes in carnitine levels through induction chemotherapy in head and neck cancer patients as a potential cause of therapy-related malaise.
BACKGROUND
Carnitine is related to malaise, and cisplatin is associated with decreased carnitine. The purpose of this study was to elucidate the effects of one course of induction... | CISPLATIN, DOCETAXEL, FLUOROURACIL | DrugsGivenReaction | CC BY | 34182942 | 20,551,624 | 2021-06-28 |
What was the administration route of drug 'CISPLATIN'? | Changes in carnitine levels through induction chemotherapy in head and neck cancer patients as a potential cause of therapy-related malaise.
BACKGROUND
Carnitine is related to malaise, and cisplatin is associated with decreased carnitine. The purpose of this study was to elucidate the effects of one course of induction... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 34182942 | 20,551,624 | 2021-06-28 |
What was the administration route of drug 'DOCETAXEL'? | Changes in carnitine levels through induction chemotherapy in head and neck cancer patients as a potential cause of therapy-related malaise.
BACKGROUND
Carnitine is related to malaise, and cisplatin is associated with decreased carnitine. The purpose of this study was to elucidate the effects of one course of induction... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 34182942 | 20,551,624 | 2021-06-28 |
What was the administration route of drug 'FLUOROURACIL'? | Changes in carnitine levels through induction chemotherapy in head and neck cancer patients as a potential cause of therapy-related malaise.
BACKGROUND
Carnitine is related to malaise, and cisplatin is associated with decreased carnitine. The purpose of this study was to elucidate the effects of one course of induction... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 34182942 | 20,551,624 | 2021-06-28 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Acute respiratory failure'. | Pneumocystis in metastatic lung cancer, a pragmatic approach in support of prophylaxis.
Lung cancer prognosis has improved in the last decade, including in patients with brain metastasis. However, few of these patients who receive corticosteroids have a primary prophylaxis for Pneumocystis jirovecii pneumonia (PJP). We... | METHYLPREDNISOLONE, SPIRAMYCIN | DrugsGivenReaction | CC BY-NC | 34183310 | 19,655,955 | 2021-06-28 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Pneumocystis jirovecii pneumonia'. | Pneumocystis in metastatic lung cancer, a pragmatic approach in support of prophylaxis.
Lung cancer prognosis has improved in the last decade, including in patients with brain metastasis. However, few of these patients who receive corticosteroids have a primary prophylaxis for Pneumocystis jirovecii pneumonia (PJP). We... | METHYLPREDNISOLONE, SPIRAMYCIN | DrugsGivenReaction | CC BY-NC | 34183310 | 19,655,955 | 2021-06-28 |
What was the outcome of reaction 'Acute respiratory failure'? | Pneumocystis in metastatic lung cancer, a pragmatic approach in support of prophylaxis.
Lung cancer prognosis has improved in the last decade, including in patients with brain metastasis. However, few of these patients who receive corticosteroids have a primary prophylaxis for Pneumocystis jirovecii pneumonia (PJP). We... | Fatal | ReactionOutcome | CC BY-NC | 34183310 | 19,655,955 | 2021-06-28 |
What was the outcome of reaction 'Pneumocystis jirovecii pneumonia'? | Pneumocystis in metastatic lung cancer, a pragmatic approach in support of prophylaxis.
Lung cancer prognosis has improved in the last decade, including in patients with brain metastasis. However, few of these patients who receive corticosteroids have a primary prophylaxis for Pneumocystis jirovecii pneumonia (PJP). We... | Fatal | ReactionOutcome | CC BY-NC | 34183310 | 19,655,955 | 2021-06-28 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Disease progression'. | Response to lorlatinib on a patient with ALK-rearranged non-small cell lung cancer harboring 1151Tins mutation with uterine metastasis.
We describe a case of an anaplastic lymphoma kinase (ALK)-rearranged non-small cell lung cancer with development of uterine metastasis after crizotinib and alectinib treatment. Gene an... | CISPLATIN, DOCETAXEL, PEMETREXED, VINORELBINE TARTRATE | DrugsGivenReaction | CC BY | 34184417 | 19,930,420 | 2021-08 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Colorectal cancer metastatic'. | The efficacy of anti-EGFR therapy in treating metastatic colorectal cancer differs between the middle/low rectum and the left-sided colon.
Clinically, metastatic rectal cancer has been considered a subset of left-sided colon cancer. However, heterogeneity has been proposed to exist between high and middle/low rectal ca... | PANITUMUMAB | DrugsGivenReaction | CC BY | 34188197 | 19,532,872 | 2021-09 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Death'. | The efficacy of anti-EGFR therapy in treating metastatic colorectal cancer differs between the middle/low rectum and the left-sided colon.
Clinically, metastatic rectal cancer has been considered a subset of left-sided colon cancer. However, heterogeneity has been proposed to exist between high and middle/low rectal ca... | PANITUMUMAB | DrugsGivenReaction | CC BY | 34188197 | 19,532,872 | 2021-09 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Therapeutic product effect incomplete'. | The efficacy of anti-EGFR therapy in treating metastatic colorectal cancer differs between the middle/low rectum and the left-sided colon.
Clinically, metastatic rectal cancer has been considered a subset of left-sided colon cancer. However, heterogeneity has been proposed to exist between high and middle/low rectal ca... | PANITUMUMAB | DrugsGivenReaction | CC BY | 34188197 | 19,532,872 | 2021-09 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Therapy non-responder'. | The efficacy of anti-EGFR therapy in treating metastatic colorectal cancer differs between the middle/low rectum and the left-sided colon.
Clinically, metastatic rectal cancer has been considered a subset of left-sided colon cancer. However, heterogeneity has been proposed to exist between high and middle/low rectal ca... | PANITUMUMAB | DrugsGivenReaction | CC BY | 34188197 | 19,532,872 | 2021-09 |
What was the outcome of reaction 'Death'? | The efficacy of anti-EGFR therapy in treating metastatic colorectal cancer differs between the middle/low rectum and the left-sided colon.
Clinically, metastatic rectal cancer has been considered a subset of left-sided colon cancer. However, heterogeneity has been proposed to exist between high and middle/low rectal ca... | Fatal | ReactionOutcome | CC BY | 34188197 | 19,532,872 | 2021-09 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Anaemia neonatal'. | A Case of Sepsis Due to Carbapenem-Resistant Klebsiella pneumoniae in an Extremely Low-Birth Weight Infant Treated with Trimethoprim-Sulfamethoxazole.
In recent years, there have been an increasing number of infections due to multidrug-resistant organisms in the neonatal intensive care unit. Carbapenem-resistant Klebsi... | CAFFEINE, CEFOPERAZONE SODIUM\SULBACTAM SODIUM, MEROPENEM, VANCOMYCIN | DrugsGivenReaction | CC BY-NC | 34188498 | 19,626,457 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug ineffective'. | A Case of Sepsis Due to Carbapenem-Resistant Klebsiella pneumoniae in an Extremely Low-Birth Weight Infant Treated with Trimethoprim-Sulfamethoxazole.
In recent years, there have been an increasing number of infections due to multidrug-resistant organisms in the neonatal intensive care unit. Carbapenem-resistant Klebsi... | CAFFEINE, CEFOPERAZONE SODIUM\SULBACTAM SODIUM, MEROPENEM, VANCOMYCIN | DrugsGivenReaction | CC BY-NC | 34188498 | 19,626,457 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Hepatic function abnormal'. | A Case of Sepsis Due to Carbapenem-Resistant Klebsiella pneumoniae in an Extremely Low-Birth Weight Infant Treated with Trimethoprim-Sulfamethoxazole.
In recent years, there have been an increasing number of infections due to multidrug-resistant organisms in the neonatal intensive care unit. Carbapenem-resistant Klebsi... | AMINO ACIDS\DEXTROSE\ELECTROLYTES NOS\SOYBEAN OIL, AMPICILLIN SODIUM\SULBACTAM SODIUM, CAFFEINE, CEFOPERAZONE SODIUM\SULBACTAM SODIUM, CEFTAZIDIME, MEROPENEM, SULFAMETHOXAZOLE\TRIMETHOPRIM, VANCOMYCIN | DrugsGivenReaction | CC BY-NC | 34188498 | 19,693,462 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Pleural effusion'. | A Case of Sepsis Due to Carbapenem-Resistant Klebsiella pneumoniae in an Extremely Low-Birth Weight Infant Treated with Trimethoprim-Sulfamethoxazole.
In recent years, there have been an increasing number of infections due to multidrug-resistant organisms in the neonatal intensive care unit. Carbapenem-resistant Klebsi... | AMINO ACIDS\DEXTROSE\ELECTROLYTES NOS\SOYBEAN OIL, AMPICILLIN SODIUM\SULBACTAM SODIUM, CAFFEINE, CEFOPERAZONE SODIUM\SULBACTAM SODIUM, CEFTAZIDIME, MEROPENEM, SULFAMETHOXAZOLE\TRIMETHOPRIM, VANCOMYCIN | DrugsGivenReaction | CC BY-NC | 34188498 | 19,693,462 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Thrombocytopenia neonatal'. | A Case of Sepsis Due to Carbapenem-Resistant Klebsiella pneumoniae in an Extremely Low-Birth Weight Infant Treated with Trimethoprim-Sulfamethoxazole.
In recent years, there have been an increasing number of infections due to multidrug-resistant organisms in the neonatal intensive care unit. Carbapenem-resistant Klebsi... | CAFFEINE, CEFOPERAZONE SODIUM\SULBACTAM SODIUM, MEROPENEM, VANCOMYCIN | DrugsGivenReaction | CC BY-NC | 34188498 | 19,626,457 | 2021 |
What is the weight of the patient? | A Case of Sepsis Due to Carbapenem-Resistant Klebsiella pneumoniae in an Extremely Low-Birth Weight Infant Treated with Trimethoprim-Sulfamethoxazole.
In recent years, there have been an increasing number of infections due to multidrug-resistant organisms in the neonatal intensive care unit. Carbapenem-resistant Klebsi... | .97 kg. | Weight | CC BY-NC | 34188498 | 19,626,457 | 2021 |
What was the administration route of drug 'AMINO ACIDS\DEXTROSE\ELECTROLYTES NOS\SOYBEAN OIL'? | A Case of Sepsis Due to Carbapenem-Resistant Klebsiella pneumoniae in an Extremely Low-Birth Weight Infant Treated with Trimethoprim-Sulfamethoxazole.
In recent years, there have been an increasing number of infections due to multidrug-resistant organisms in the neonatal intensive care unit. Carbapenem-resistant Klebsi... | Parenteral | DrugAdministrationRoute | CC BY-NC | 34188498 | 19,693,462 | 2021 |
What was the administration route of drug 'VANCOMYCIN'? | A Case of Sepsis Due to Carbapenem-Resistant Klebsiella pneumoniae in an Extremely Low-Birth Weight Infant Treated with Trimethoprim-Sulfamethoxazole.
In recent years, there have been an increasing number of infections due to multidrug-resistant organisms in the neonatal intensive care unit. Carbapenem-resistant Klebsi... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC | 34188498 | 19,626,457 | 2021 |
What was the dosage of drug 'SULFAMETHOXAZOLE\TRIMETHOPRIM'? | A Case of Sepsis Due to Carbapenem-Resistant Klebsiella pneumoniae in an Extremely Low-Birth Weight Infant Treated with Trimethoprim-Sulfamethoxazole.
In recent years, there have been an increasing number of infections due to multidrug-resistant organisms in the neonatal intensive care unit. Carbapenem-resistant Klebsi... | 20 MILLIGRAM/KILOGRAM, BID ( (10 DAYS) | DrugDosageText | CC BY-NC | 34188498 | 19,693,462 | 2021 |
What was the outcome of reaction 'Anaemia neonatal'? | A Case of Sepsis Due to Carbapenem-Resistant Klebsiella pneumoniae in an Extremely Low-Birth Weight Infant Treated with Trimethoprim-Sulfamethoxazole.
In recent years, there have been an increasing number of infections due to multidrug-resistant organisms in the neonatal intensive care unit. Carbapenem-resistant Klebsi... | Recovering | ReactionOutcome | CC BY-NC | 34188498 | 19,626,457 | 2021 |
What was the outcome of reaction 'Drug ineffective'? | A Case of Sepsis Due to Carbapenem-Resistant Klebsiella pneumoniae in an Extremely Low-Birth Weight Infant Treated with Trimethoprim-Sulfamethoxazole.
In recent years, there have been an increasing number of infections due to multidrug-resistant organisms in the neonatal intensive care unit. Carbapenem-resistant Klebsi... | Recovered | ReactionOutcome | CC BY-NC | 34188498 | 19,626,457 | 2021 |
What was the outcome of reaction 'Hepatic function abnormal'? | A Case of Sepsis Due to Carbapenem-Resistant Klebsiella pneumoniae in an Extremely Low-Birth Weight Infant Treated with Trimethoprim-Sulfamethoxazole.
In recent years, there have been an increasing number of infections due to multidrug-resistant organisms in the neonatal intensive care unit. Carbapenem-resistant Klebsi... | Recovered | ReactionOutcome | CC BY-NC | 34188498 | 19,693,462 | 2021 |
What was the outcome of reaction 'Thrombocytopenia neonatal'? | A Case of Sepsis Due to Carbapenem-Resistant Klebsiella pneumoniae in an Extremely Low-Birth Weight Infant Treated with Trimethoprim-Sulfamethoxazole.
In recent years, there have been an increasing number of infections due to multidrug-resistant organisms in the neonatal intensive care unit. Carbapenem-resistant Klebsi... | Recovered | ReactionOutcome | CC BY-NC | 34188498 | 19,626,457 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Blood sodium increased'. | Intraoperative central diabetes insipidus in a postpartum patient during decompression of base of brain lesion: Missing out the diagnosis of Sheehan's syndrome?
A 35-year-old female presented with headache in the third week postpartum period following uneventful cesarean delivery. She had left sided ptosis, pain, and n... | DEXAMETHASONE | DrugsGivenReaction | CC BY-NC-SA | 34188642 | 20,215,294 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Unmasking of previously unidentified disease'. | Intraoperative central diabetes insipidus in a postpartum patient during decompression of base of brain lesion: Missing out the diagnosis of Sheehan's syndrome?
A 35-year-old female presented with headache in the third week postpartum period following uneventful cesarean delivery. She had left sided ptosis, pain, and n... | DEXAMETHASONE, FENTANYL, PROPOFOL | DrugsGivenReaction | CC BY-NC-SA | 34188642 | 20,178,215 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Urine output increased'. | Intraoperative central diabetes insipidus in a postpartum patient during decompression of base of brain lesion: Missing out the diagnosis of Sheehan's syndrome?
A 35-year-old female presented with headache in the third week postpartum period following uneventful cesarean delivery. She had left sided ptosis, pain, and n... | DEXAMETHASONE | DrugsGivenReaction | CC BY-NC-SA | 34188642 | 20,215,294 | 2021 |
What is the weight of the patient? | Intraoperative central diabetes insipidus in a postpartum patient during decompression of base of brain lesion: Missing out the diagnosis of Sheehan's syndrome?
A 35-year-old female presented with headache in the third week postpartum period following uneventful cesarean delivery. She had left sided ptosis, pain, and n... | 79 kg. | Weight | CC BY-NC-SA | 34188642 | 20,215,294 | 2021 |
What was the dosage of drug 'DEXAMETHASONE'? | Intraoperative central diabetes insipidus in a postpartum patient during decompression of base of brain lesion: Missing out the diagnosis of Sheehan's syndrome?
A 35-year-old female presented with headache in the third week postpartum period following uneventful cesarean delivery. She had left sided ptosis, pain, and n... | 8 mg (milligrams). | DrugDosage | CC BY-NC-SA | 34188642 | 20,178,215 | 2021 |
What was the outcome of reaction 'Diabetes insipidus'? | Intraoperative central diabetes insipidus in a postpartum patient during decompression of base of brain lesion: Missing out the diagnosis of Sheehan's syndrome?
A 35-year-old female presented with headache in the third week postpartum period following uneventful cesarean delivery. She had left sided ptosis, pain, and n... | Recovered with sequelae (consequent health issues) | ReactionOutcome | CC BY-NC-SA | 34188642 | 20,178,215 | 2021 |
What was the outcome of reaction 'Unmasking of previously unidentified disease'? | Intraoperative central diabetes insipidus in a postpartum patient during decompression of base of brain lesion: Missing out the diagnosis of Sheehan's syndrome?
A 35-year-old female presented with headache in the third week postpartum period following uneventful cesarean delivery. She had left sided ptosis, pain, and n... | Recovered with sequelae (consequent health issues) | ReactionOutcome | CC BY-NC-SA | 34188642 | 20,178,215 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Osteonecrosis of jaw'. | Photobiomodulation laser therapy in a Lenvatinib-related osteonecrosis of the jaw: A case report.
Medication-related osteonecrosis of the jaw (MRONJ) is a serious adverse drug reaction often presenting as a post-surgery complication that may interfere in the quality of the patient's life. In the last decade, additional... | LENVATINIB | DrugsGivenReaction | CC BY | 34188771 | 19,564,861 | 2021-06 |
What was the administration route of drug 'LENVATINIB'? | Photobiomodulation laser therapy in a Lenvatinib-related osteonecrosis of the jaw: A case report.
Medication-related osteonecrosis of the jaw (MRONJ) is a serious adverse drug reaction often presenting as a post-surgery complication that may interfere in the quality of the patient's life. In the last decade, additional... | Oral | DrugAdministrationRoute | CC BY | 34188771 | 19,564,861 | 2021-06 |
What was the dosage of drug 'LENVATINIB'? | Photobiomodulation laser therapy in a Lenvatinib-related osteonecrosis of the jaw: A case report.
Medication-related osteonecrosis of the jaw (MRONJ) is a serious adverse drug reaction often presenting as a post-surgery complication that may interfere in the quality of the patient's life. In the last decade, additional... | 24 mg (milligrams). | DrugDosage | CC BY | 34188771 | 19,564,861 | 2021-06 |
What was the outcome of reaction 'Osteonecrosis of jaw'? | Photobiomodulation laser therapy in a Lenvatinib-related osteonecrosis of the jaw: A case report.
Medication-related osteonecrosis of the jaw (MRONJ) is a serious adverse drug reaction often presenting as a post-surgery complication that may interfere in the quality of the patient's life. In the last decade, additional... | Recovered | ReactionOutcome | CC BY | 34188771 | 19,564,861 | 2021-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Ecchymosis'. | Drug-induced immune-mediated thrombocytopenia secondary to durvalumab use.
Immunotherapy is an expanding area of cancer treatment with significant promise. Despite their efficacy, checkpoint inhibitors are associated with a number of immune-related adverse events; here, we described thrombocytopenia secondary todurvalu... | DURVALUMAB, PREDNISONE | DrugsGivenReaction | CC BY-NC-ND | 34188921 | 19,998,093 | 2021-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Thrombocytopenia'. | Drug-induced immune-mediated thrombocytopenia secondary to durvalumab use.
Immunotherapy is an expanding area of cancer treatment with significant promise. Despite their efficacy, checkpoint inhibitors are associated with a number of immune-related adverse events; here, we described thrombocytopenia secondary todurvalu... | DURVALUMAB, PREDNISONE | DrugsGivenReaction | CC BY-NC-ND | 34188921 | 19,998,093 | 2021-06 |
What was the administration route of drug 'DURVALUMAB'? | Drug-induced immune-mediated thrombocytopenia secondary to durvalumab use.
Immunotherapy is an expanding area of cancer treatment with significant promise. Despite their efficacy, checkpoint inhibitors are associated with a number of immune-related adverse events; here, we described thrombocytopenia secondary todurvalu... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC-ND | 34188921 | 19,998,093 | 2021-06 |
What was the outcome of reaction 'Thrombocytopenia'? | Drug-induced immune-mediated thrombocytopenia secondary to durvalumab use.
Immunotherapy is an expanding area of cancer treatment with significant promise. Despite their efficacy, checkpoint inhibitors are associated with a number of immune-related adverse events; here, we described thrombocytopenia secondary todurvalu... | Recovered | ReactionOutcome | CC BY-NC-ND | 34188921 | 19,998,093 | 2021-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Off label use'. | Transient disappearance of CD19+/CD5+ B-lymphocyte clone in peripheral blood in a patient with CLL during SARS-CoV-2-related mild disease.
Although lymphopenia is currently considered a good predictor for the prognosis of COVID-19, it must be critically evaluated in patients with CLL, where other clinical markers shoul... | DARUNAVIR, HYDROXYCHLOROQUINE, METFORMIN HYDROCHLORIDE, RAMIPRIL, RITONAVIR | DrugsGivenReaction | CC BY | 34188925 | 20,159,156 | 2021-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Acute kidney injury'. | Recurrent, refractory hypokalemia as a diagnostic clue to thyrotoxic periodic paralysis in a patient with acute kidney injury and suspected Guillain-Barre syndrome.
When clinical presentation is atypical, especially in a non-Asian population, the finding of recurrent and refractory hypokalemia can serve as a key diagno... | CEFTRIAXONE, DOXYCYCLINE, EFAVIRENZ\EMTRICITABINE\TENOFOVIR DISOPROXIL FUMARATE, POTASSIUM CHLORIDE, POTASSIUM PHOSPHATE, POTASSIUM PHOSPHATE, DIBASIC\POTASSIUM PHOSPHATE, MONOBASIC\SODIUM PHOSPHATE, DIBASIC\SODIUM PHOSPHA, VANCOMYCIN | DrugsGivenReaction | CC BY-NC-ND | 34188930 | 19,931,526 | 2021-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Hypokalaemia'. | Recurrent, refractory hypokalemia as a diagnostic clue to thyrotoxic periodic paralysis in a patient with acute kidney injury and suspected Guillain-Barre syndrome.
When clinical presentation is atypical, especially in a non-Asian population, the finding of recurrent and refractory hypokalemia can serve as a key diagno... | CEFTRIAXONE, DOXYCYCLINE, EFAVIRENZ\EMTRICITABINE\TENOFOVIR DISOPROXIL FUMARATE, POTASSIUM CHLORIDE, POTASSIUM PHOSPHATE, POTASSIUM PHOSPHATE, DIBASIC\POTASSIUM PHOSPHATE, MONOBASIC\SODIUM PHOSPHATE, DIBASIC\SODIUM PHOSPHA, VANCOMYCIN | DrugsGivenReaction | CC BY-NC-ND | 34188930 | 19,931,526 | 2021-06 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.